125.97
0.82%
+1.02
Pre-mercato:
125.01
-0.96
-0.76%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DXCM Giù?
Forum
Previsione
Frazionamento azionario
Dexcom Inc Borsa (DXCM) Ultime notizie
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
The Motley Fool
Should iShares Russell Mid-Cap Growth ETF (IWP) Be on Your Investing Radar?
Zacks Investment Research
Haemonetics (HAE) Banks on Plasma Arm Growth Amid Rising Costs
Zacks Investment Research
Here is Why Growth Investors Should Buy DexCom (DXCM) Now
Zacks Investment Research
Ecolab (ECL) Q1 Earnings Surpass Estimates, Margins Rise
Zacks Investment Research
QIAGEN (QGEN) Q1 Earnings Top Estimates, Margins Expand
Zacks Investment Research
DexCom, Inc. (DXCM) Is a Trending Stock: Facts to Know Before Betting on It
Zacks Investment Research
Here's Why You Should Buy Bruker (BRKR) Stock Right Now
Zacks Investment Research
Here's Why DexCom (DXCM) is a Strong Growth Stock
Zacks Investment Research
DexCom (DXCM) Q1 Earnings Beat, Strong CGM Demand Continues
Zacks Investment Research
DexCom (DXCM) Q1 2024 Earnings Call Transcript
The Motley Fool
DexCom (DXCM) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Zacks Investment Research
Wall Street Bulls Look Optimistic About DexCom (DXCM): Should You Buy?
Zacks Investment Research
DexCom (DXCM) to Report Q1 Earnings: What's in the Cards?
Zacks Investment Research
Ahead of DexCom (DXCM) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Zacks Investment Research
Zacks Investment Ideas feature highlights: Vertiv, Align Technology and DexCom
Zacks Investment Research
3 Innovative Stocks to Buy Before Earnings Amid the Market Pullback
Zacks Investment Research
Reasons to Retain DexCom (DXCM) Stock in Your Portfolio for Now
Zacks Investment Research
Zacks Industry Outlook Highlights Edwards Lifesciences, DexCom and STERIS
Zacks Investment Research
DexCom (DXCM) Stock Moves -1.16%: What You Should Know
Zacks Investment Research
3 Medical Instruments Stocks to Buy Amid Improving Industry Trends
Zacks Investment Research
DexCom (DXCM), MD Revolution Unite to Boost Diabetes Management
Zacks Investment Research
Is DexCom (DXCM) Outperforming Other Medical Stocks This Year?
Zacks Investment Research
The Analyst Verdict: DexCom In The Eyes Of 4 Experts
Benzinga
Should First Trust Growth Strength ETF (FTGS) Be on Your Investing Radar?
Zacks Investment Research
Why the Market Dipped But DexCom (DXCM) Gained Today
Zacks Investment Research
2 Growth Stocks to Buy Hand Over Fist in April
The Motley Fool
DexCom, Inc. (DXCM) is Attracting Investor Attention: Here is What You Should Know
Zacks Investment Research
DexCom (DXCM) Falls More Steeply Than Broader Market: What Investors Need to Know
Zacks Investment Research
Tenet (THC) Divests Six Hospitals, Sustains Divestiture Spree
Zacks Investment Research
Micron, Dropbox And 2 Other Stocks Insiders Are Selling
Benzinga
Market Cap Game Show: Andy Cross vs. Bill Mann
The Motley Fool
DexCom (DXCM) Upgraded to Buy: What Does It Mean for the Stock?
Zacks Investment Research
DexCom (DXCM) Hits 52-Week High: What's Driving the Stock?
Zacks Investment Research
DexCom (DXCM) Stock Moves -0.12%: What You Should Know
Zacks Investment Research
Has DexCom (DXCM) Outpaced Other Medical Stocks This Year?
Zacks Investment Research
Compelling Reasons to Hold on to UnitedHealth Group (UNH) Stock
Zacks Investment Research
DexCom, Inc. (DXCM) Is a Trending Stock: Facts to Know Before Betting on It
Zacks Investment Research
DexCom (DXCM) Stock Sinks As Market Gains: Here's Why
Zacks Investment Research
Reasons to Retain DexCom (DXCM) Stock in Your Portfolio for Now
Zacks Investment Research
Encompass Health (EHC) Up 42% in a Year: What Lies Ahead?
Zacks Investment Research
Buy 5 Medical Devices Stocks for a Stable Portfolio in 2024
Zacks Investment Research
Is It Worth Investing in DexCom (DXCM) Based on Wall Street's Bullish Views?
Zacks Investment Research
Zacks Investment Ideas feature highlights: Tenet Healthcare and HCA Healthcare
Zacks Investment Research
Medical Devices ETF Hits 52-Week High: Stocks to Watch
Zacks Investment Research
Roche (RHHBY) Launches AI-Based Predictive CGM Accu-Chek
Zacks Investment Research
DexCom Is 'Expanding Rapidly' With Multi-Year Runway Ahead, Bullish Analyst Says
Benzinga
Analyst Expectations For DexCom's Future
Benzinga
DexCom (DXCM) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Zacks Investment Research
2 Medical Device Stocks to Buy Hand Over Fist in March
The Motley Fool
Capitalizzazione:
|
Volume (24 ore):